Infusion of Ketamine in Severe Borderline Personality Disorder

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Infusion of Ketamine in Severe Borderline Personality Disorder trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

All recent trials (1 shown)

Not Yet RecruitingPhase 2

NCT07099534

Ketamine Infusion for Symptomatic Improvement in Severe Borderline Personality Disorder

The main objective of this pilot study is to evaluate at D9 the evolution of BPD symptoms' intensity(scale BSL-23) in severe BPD patients, after two Ketamine in…

France38 participantsStarted 2025-11-01

Treatment: IV Ketamine (0.5 mg/kg) Infusion - Two Doses Administered 24 Hours Apart for Severe Borderline Personality Disorder